A phase 2 study of epothilone B analog BMS-247550 (NSC 710428) in patients with relapsed aggressive non-Hodgkin lymphomas
about
Beyond taxanes: a review of novel agents that target mitotic tubulin and microtubules, kinases, and kinesins.Recent Advances in the Development of Antineoplastic Agents Derived from Natural ProductsIntramolecular oxo-Diels-Alder rearrangement in collisionally activated dissociation of protonated ions of a mactrocyclic molecule: triazole-epothilone dimer.
P2860
A phase 2 study of epothilone B analog BMS-247550 (NSC 710428) in patients with relapsed aggressive non-Hodgkin lymphomas
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A phase 2 study of epothilone ...... gressive non-Hodgkin lymphomas
@ast
A phase 2 study of epothilone ...... gressive non-Hodgkin lymphomas
@en
type
label
A phase 2 study of epothilone ...... gressive non-Hodgkin lymphomas
@ast
A phase 2 study of epothilone ...... gressive non-Hodgkin lymphomas
@en
prefLabel
A phase 2 study of epothilone ...... gressive non-Hodgkin lymphomas
@ast
A phase 2 study of epothilone ...... gressive non-Hodgkin lymphomas
@en
P2093
P2860
P356
P1433
P1476
A phase 2 study of epothilone ...... gressive non-Hodgkin lymphomas
@en
P2093
Barbara Pro
Fredrick Hagemeister
James L Wade
Jane E Churpek
Justin Kline
Kathy Conner
Koen van Besien
Sonali M Smith
Theodore Karrison
P2860
P304
P356
10.1002/CNCR.27917
P407
P50
P577
2013-01-10T00:00:00Z